Clinical Trial Update: A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the bioavailability of Rocatinlimab administered via autoinjector and vial in healthy participants. Sponsored by Amgen, the trial rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Rocatinlimab (rocatinlimab)

Snippet

Sponsor: Amgen | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED